A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Astellas Pharma Inc
Astellas Pharma Inc
Celgene
Istari Oncology, Inc.
Bristol-Myers Squibb
INSYS Therapeutics Inc
Eli Lilly and Company